Logo image of ROVR.CA

ROVER CRITICAL MINERALS CORP (ROVR.CA) Stock Fundamental Analysis

TSX-V:ROVR - TSX Venture Exchange - CA77935R1082 - Common Stock - Currency: CAD

0.02  +0.01 (+100%)

Fundamental Rating

0

Overall ROVR gets a fundamental rating of 0 out of 10. We evaluated ROVR against 0 industry peers in the Unkown industry. ROVR has a bad profitability rating. Also its financial health evaluation is rather negative. ROVR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ROVR had negative earnings in the past year.
In the past year ROVR has reported a negative cash flow from operations.
In the past 5 years ROVR always reported negative net income.
In the past 5 years ROVR always reported negative operating cash flow.
ROVR.CA Yearly Net Income VS EBIT VS OCF VS FCFROVR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -25.65%
ROE -29.66%
ROIC N/A
ROA(3y)-35.14%
ROA(5y)-44.39%
ROE(3y)-40.03%
ROE(5y)-54.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROVR.CA Yearly ROA, ROE, ROICROVR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100

1.3 Margins

ROVR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ROVR.CA Yearly Profit, Operating, Gross MarginsROVR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

ROVR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ROVR has more shares outstanding
The debt/assets ratio for ROVR has been reduced compared to a year ago.
ROVR.CA Yearly Shares OutstandingROVR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ROVR.CA Yearly Total Debt VS Total AssetsROVR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

2.2 Solvency

Based on the Altman-Z score of -1.15, we must say that ROVR is in the distress zone and has some risk of bankruptcy.
ROVR has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -1.15
ROIC/WACCN/A
WACCN/A
ROVR.CA Yearly LT Debt VS Equity VS FCFROVR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

ROVR has a Current Ratio of 0.16. This is a bad value and indicates that ROVR is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.16 indicates that ROVR may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
ROVR.CA Yearly Current Assets VS Current LiabilitesROVR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K

More info and screens

0

3. Growth

3.1 Past

ROVR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.12%, which is quite impressive.
EPS 1Y (TTM)46.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ROVR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by 0.00% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2Y0%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ROVR.CA Yearly Revenue VS EstimatesROVR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
ROVR.CA Yearly EPS VS EstimatesROVR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.01 -0.02 -0.03 -0.04

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ROVR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ROVR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ROVR.CA Price Earnings VS Forward Price EarningsROVR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ROVR.CA Per share dataROVR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0%
EPS Next 3Y0%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ROVR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROVER CRITICAL MINERALS CORP

TSX-V:ROVR (2/21/2025, 7:00:00 PM)

0.02

+0.01 (+100%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners27.33%
Ins Owner ChangeN/A
Market Cap1.43M
Analysts80
Price Target0.63 (3050%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.65%
ROE -29.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.14%
ROA(5y)-44.39%
ROE(3y)-40.03%
ROE(5y)-54.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z -1.15
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.44%
EPS Next Y0%
EPS Next 2Y0%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.33%
EBIT Next 3Y2.17%
EBIT Next 5YN/A
FCF growth 1Y72.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.75%
OCF growth 3YN/A
OCF growth 5YN/A